Effects of Insulin-Like Growth Factor-1 on Neurotransmitters of Memory
ISEF · 2019 Biochemistry
Overview
Background: Alzheimer’s dementia (AD) is characterized by profound memory loss. New models of treatment are needed since the prevailing amyloid hypothesis has not resulted in successful treatments. Changes in effectiveness of neurotransmission may alter learning and memory. Diabetes is an important risk factor for AD and insulin has previously been shown to affect neurotransmission. But little is known about a structurally similar protein that exists in the central nervous system: insulin-like growth factor-1 (IGF1). My goal was to find if IGF1 would positively or negatively affect the responses of neuronal cells to the neurotransmitter glutamate. Methods: Rat cortical neuron cell cultures were prepared and monitored for intracellular calcium levels under standardized conditions at regular intervals during application of glutamate receptor agonists in the presence or absence of insulin, IGF1, and inhibitors of specific glutamate receptors (e.g., CNQX). Results: In contrast to insulin, calcium influx in response to glutamate was significantly inhibited by IGF1. However, when NMDA receptors were isolated by the application of CNQX, the calcium influx through this class of receptor was elevated, consistent with the effects of insulin. Isolation of AMPA receptors by APV showed reduction in calcium influx, indicating that they were responsible for the main effect of IGF1 on responses to glutamate. Conclusion: IGF1 influences NMDA receptors similarly to insulin but has an opposite effect on the overall response to glutamate in cultures of rat cortical neurons. This indicates IGF1 has a unique role in processes related to neurotransmission and perhaps memory in AD.
Competition history
- ISEF 2019
Resources
Related projects
ISEF · 2026
The Influence of Neurotransmitters on IGF-2 and IGF2R Expression in Cell Models
ISEF · 2024
Alterations in Neuromodulatory Proteins in Single APP Knock-in Mice Assessed Following Ketamine Therapy
ISEF · 2014
Alzheimer’s Disease: The Effect of Neuregulin1/ErbB4 Back Signaling on Gamma Secretase Production
ISEF · 2016
Reducing the Risk of Alzheimer's in Type II Diabetes Patients
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair